PUBLISHER: The Business Research Company | PRODUCT CODE: 1947127
PUBLISHER: The Business Research Company | PRODUCT CODE: 1947127
Single incision laparoscopic surgery (SILS) is a minimally invasive procedure in which surgeons operate through a single entry point, usually the navel, using specialized instruments and a laparoscope. This technique offers cosmetic advantages with nearly scar-free results, while also promoting faster recovery, reduced postoperative pain, and a lower risk of complications compared to traditional multi-port laparoscopic surgery.
The primary types of products used in single-incision laparoscopic surgery include surgical instruments, access devices, closure devices, and others. Surgical instruments are precision tools designed to perform operations through a single small incision, minimizing tissue damage. SILS is employed in various procedures such as cholecystectomy, appendectomy, colectomy, hernia repair, bariatric surgery, and more. These products are utilized by a wide range of end users, including hospitals, ambulatory surgical centers, specialty clinics, and other healthcare facilities.
Tariffs are impacting the single incision laparoscopic surgery market by increasing costs for imported surgical instruments, access platforms, and advanced laparoscopic devices. Product segments such as single-port access devices and specialized instruments are most affected, particularly in Asia-Pacific and Latin American regions dependent on imports. These cost pressures have slowed adoption in price-sensitive markets. However, tariffs have encouraged local manufacturing, regional supplier development, and cost-optimized instrument innovation, supporting long-term market sustainability.
The single incision laparoscopic surgery market research report is one of a series of new reports from The Business Research Company that provides single incision laparoscopic surgery market statistics, including single incision laparoscopic surgery industry global market size, regional shares, competitors with a single incision laparoscopic surgery market share, detailed single incision laparoscopic surgery market segments, market trends and opportunities, and any further data you may need to thrive in the single incision laparoscopic surgery industry. This single incision laparoscopic surgery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The single incision laparoscopic surgery market size has grown strongly in recent years. It will grow from $3.08 billion in 2025 to $3.39 billion in 2026 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to adoption of conventional laparoscopic surgery, growing surgical volume worldwide, patient preference for minimally invasive procedures, advancements in laparoscopic instruments, increasing hospital infrastructure.
The single incision laparoscopic surgery market size is expected to see strong growth in the next few years. It will grow to $4.9 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to expansion of robotic-assisted sils procedures, rising demand for outpatient surgeries, technological innovation in access and closure devices, growing bariatric and hernia procedures, increasing healthcare investment in advanced surgery. Major trends in the forecast period include rising preference for minimally invasive surgical techniques, growing demand for scar-less and cosmetic surgical outcomes, increasing adoption of single-port surgical instruments, shorter hospital stay and faster patient recovery, rising surgeon training and skill development in sils.
The increasing preference for minimally invasive procedures is expected to drive the growth of the single incision laparoscopic surgery (SILS) market in the coming years. Minimally invasive procedures involve medical or surgical techniques performed through small incisions or natural openings to reduce tissue damage, pain, and recovery time. Their popularity is growing because they lead to faster recovery, less discomfort, and shorter hospital stays. SILS further minimizes invasiveness by using a single small entry point, which reduces tissue trauma, resulting in less pain, quicker healing, and fewer scars compared to traditional multi-port surgeries. For example, in August 2023, The Aesthetic Society, a U.S.-based organization for plastic surgery and cosmetic medicine, reported that Americans spent over $11.8 billion on aesthetic procedures, a 2% increase from the previous year. Consequently, the rising preference for minimally invasive procedures is boosting the single incision laparoscopic surgery market.
Companies in the SILS market are focusing on innovations such as single-port robotic surgery to improve surgical precision and expand the range of minimally invasive procedures. Single-port robotic surgery uses robotic systems to perform operations through a single small incision, offering enhanced accuracy and faster patient recovery. For instance, in April 2025, Intuitive Surgical, Inc., a U.S.-based provider of minimally invasive technology, received FDA clearance for the SureForm 45 stapler. Designed for use with the da Vinci SP surgical system in urologic, thoracic, and colorectal procedures, it features SmartFire technology, which continuously monitors tissue compression during stapling to optimize staple line integrity and reduce tissue damage. The device allows surgeons to control stapling from the console, reducing the need for an assistant while using wristed instruments and a 3D camera to minimize instrument collisions in confined surgical spaces.
In November 2024, Medtronic plc, an Ireland-based medical technology company, acquired Fortimedix Surgical B.V. for an undisclosed sum. This acquisition enables Medtronic to expand its surgical and endoscopy portfolio by incorporating Fortimedix's laser-cut articulating instruments, strengthening its capabilities in minimally invasive and robotic-assisted surgeries, and supporting the development of its Hugo soft-tissue robotic system. Fortimedix Surgical B.V., based in the Netherlands, specializes in minimally invasive surgery and offers a single-port laparoscopic surgery platform.
Major companies operating in the single incision laparoscopic surgery market are Medtronic plc, Stryker Corporation, Boston Scientific Corporation, B Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc., Karl Storz SE & Co. KG, Cook Medical Inc., Applied Medical Resources Corporation, Burjeel Hospital, Fortis Healthcare Limited, Richard Wolf GmbH, Peters Surgical, Geyi Medical Instrument, Levita Magnetics, Millennium Surgical Corp., Asensus Surgical Inc., Surtex Instruments Limited, Johnson & Johnson Ethicon, CONMED Corporation, Smith and Nephew PLC, CMR Surgical Ltd, Genesis MedTech
North America was the largest region in the single incision laparoscopic surgeries market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single incision laparoscopic surgery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the single incision laparoscopic surgery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The single-incision laparoscopic surgery market consists of revenues earned by entities by providing services such as diagnostic laparoscopy, nephrectomy, splenectomy, and hysterectomy. The market value includes the value of related goods sold by the service provider or included within the service offering. The single-incision laparoscopic surgeries market also includes sales of insufflation systems, laparoscopes, suturing and stapling devices, single-use or reusable trocar systems, and training simulators and kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Single Incision Laparoscopic Surgery Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses single incision laparoscopic surgery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for single incision laparoscopic surgery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The single incision laparoscopic surgery market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.